Turing Biosystems

Artificial intelligence to select targets for oncology drugs. Turing Bio use automated reasoning to analyse multiomics data and identify the molecular origin of a disease.

Summary

University:

Stage:

Pre-Seed

Sector:

Life Science

Investment year:

2022